Hirono Tsutsumi

TP53 gain-of-function mutations promote osimertinib resistance via TNF-α–NF-κB signaling in EGFR-mutated lung cancer

Ritsu Ibusuki, Eiji Iwama, Atsushi Shimauchi et al. · npj Precision Oncology · 2024 · 32 citations · Full text

Cytotoxic chemotherapeutic agents and the EGFR-TKI osimertinib induce calreticulin exposure in non–small cell lung cancer

Rie Furukawa, Hiroyuki Inoue, Yasuto Yoneshima et al. · Lung Cancer · 2021 · 21 citations · Full text

Cytotoxic Chemotherapeutic Agents, Cell Lung Cancer, Medicine +8

Increased plasma levels of damage-associated molecular patterns during systemic anticancer therapy in patients with advanced lung cancer

Hiroyuki Inoue, Hirono Tsutsumi, Kentaro Tanaka et al. · Translational Lung Cancer Research · 2021 · 20 citations · Full text

Regulation of PD-L1 expression in non–small cell lung cancer by interleukin-1β

Aiko Hirayama, Kentaro Tanaka, Hirono Tsutsumi et al. · Frontiers in Immunology · 2023 · 19 citations · Full text